| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2000 | EP1060180A1 Process for synthesizing carbapenem antibiotics |
| 12/20/2000 | EP1060179A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials |
| 12/20/2000 | EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 12/20/2000 | EP1060177A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 12/20/2000 | EP1060175A2 Tryptase inhibitors |
| 12/20/2000 | EP1060174A1 Nitric oxide releasing chelating agents and their therapeutic use |
| 12/20/2000 | EP1060173A2 Benzazine derivatives phosphodiesterase 4 inhibitors |
| 12/20/2000 | EP1060171A2 Tryptase inhibitors |
| 12/20/2000 | EP1060169A1 1,4-diazacycloheptane derivatives |
| 12/20/2000 | EP1060168A2 Method for preparing sulfanyl-type endothelin receptor antagonists |
| 12/20/2000 | EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists |
| 12/20/2000 | EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents |
| 12/20/2000 | EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
| 12/20/2000 | EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 12/20/2000 | EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 12/20/2000 | EP1060161A1 Matrix metalloproteinase inhibitors |
| 12/20/2000 | EP1060160A2 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs |
| 12/20/2000 | EP1060011A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles |
| 12/20/2000 | EP1059942A2 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 12/20/2000 | EP1059941A1 Pharmaceutical compositions and their use |
| 12/20/2000 | EP1059940A2 Method for treating painful conditions of the anal region and compositions therefor |
| 12/20/2000 | EP1059933A1 Method of increasing bone toughness and stiffness and reducing fractures |
| 12/20/2000 | EP1059930A1 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
| 12/20/2000 | EP1059927A1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 12/20/2000 | EP1059926A2 PROSTAGLANDIN E 2?/F 2$g(a)? COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL |
| 12/20/2000 | EP1059925A1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 12/20/2000 | EP1059924A1 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases |
| 12/20/2000 | EP1059923A1 Combination of a selective nmda nr2b antagonist and an opioid analgesic |
| 12/20/2000 | EP1059922A2 Glycine transport inhibitors |
| 12/20/2000 | EP1059921A2 Use of macrolide compounds for the treatment of ards |
| 12/20/2000 | EP1059920A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 12/20/2000 | EP1059919A1 Small molecules that increase the conversion of food to body weight gain |
| 12/20/2000 | EP1059918A1 Novel dosage form |
| 12/20/2000 | EP1059917A1 Anti-asthma therapy |
| 12/20/2000 | EP1059916A1 Extended release dosage form |
| 12/20/2000 | EP1059915A1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 12/20/2000 | EP1059914A2 Method for producing solid, spherical forms containing pharmaceutical active agents in a binder matrix |
| 12/20/2000 | EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/20/2000 | EP1059911A1 Formulations with an anti-viral effect |
| 12/20/2000 | EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 12/20/2000 | EP1059845A1 Fungicide composition comprising a benzoylphenylurea |
| 12/20/2000 | EP1059843A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
| 12/20/2000 | EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 12/20/2000 | EP0928522B1 Method for adapting a receiver to transmission conditions, and the adequate receiver |
| 12/20/2000 | EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 12/20/2000 | EP0842148B1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 12/20/2000 | EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS |
| 12/20/2000 | EP0801642B1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same |
| 12/20/2000 | EP0800385B1 Oral sustained-release preparation |
| 12/20/2000 | EP0788352B1 Treatment of animals |
| 12/20/2000 | EP0754030B1 Method for stabilizing duocarmycin derivatives |
| 12/20/2000 | EP0751944B1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents |
| 12/20/2000 | EP0739203A4 Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
| 12/20/2000 | EP0737065B1 Process for preparing solid pharmaceutical dosage forms |
| 12/20/2000 | EP0726898B1 Phenylindole compounds |
| 12/20/2000 | EP0717615B1 Multi-phase compositions for an initial and delayed release of a medicament |
| 12/20/2000 | EP0714295B1 Fibrinogen receptor antagonists |
| 12/20/2000 | EP0700378B1 Compounds which release nitric oxide |
| 12/20/2000 | EP0543858B1 Benzimidazole derivatives, process for their preparation and application |
| 12/20/2000 | CN1277634A New tissue-specific calpaines, their production and their use |
| 12/20/2000 | CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 12/20/2000 | CN1277612A Nitrogen-containing heterocyclic compounds, their production and use |
| 12/20/2000 | CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 12/20/2000 | CN1277607A 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5-HT1b and 5-HT1D) |
| 12/20/2000 | CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 12/20/2000 | CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 12/20/2000 | CN1277555A Composition for improving mental capabilities in mammals |
| 12/20/2000 | CN1277554A Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 12/20/2000 | CN1277552A Nitric oxide inhibits rhinovirus infection |
| 12/20/2000 | CN1277550A Modified release multiple-units compositions of non-steroid anti-inflammatory drug sbstances (NSAIDS) |
| 12/20/2000 | CN1277549A Vesicular complexes and methods of making and using the same |
| 12/20/2000 | CN1277540A Soy formulations and their use for promoting health |
| 12/20/2000 | CN1277198A New bicyclo aminopyrazineone compound, its producing process and medical composition containing them |
| 12/20/2000 | CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 12/20/2000 | CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 12/20/2000 | CN1277192A New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them |
| 12/20/2000 | CN1277055A Burns treating ointment |
| 12/20/2000 | CN1277051A Recipe of externally applied Chinese medicine for rheumatism and asthma |
| 12/20/2000 | CN1277049A Medicine for treating breast tumor and carbuncle |
| 12/20/2000 | CN1277028A Production process of compound Meilingzhihua health food series |
| 12/20/2000 | CN1277024A Application of cationic liposome and polydeoxyribonucleosides composite using as medicament |
| 12/20/2000 | CN1277023A Veterinary tranquilizing and growth-promoting injecta |
| 12/20/2000 | CN1277022A Medical composition for treating thrombus and its use |
| 12/20/2000 | CN1277021A Impotence treating medicine spray and its preparation |
| 12/20/2000 | CN1277020A Application of Eight precious extract in preparing antiviral medicine |
| 12/20/2000 | CN1277019A Medicament for intensifing brain acetylcholine releasing |
| 12/20/2000 | CN1277016A Ointment for treating sweety feet and body odor and its preparation |
| 12/20/2000 | CN1059679C Process for producing alginic acid sodium diester |
| 12/20/2000 | CN1059674C Hypolipidemic benzothiazepines |
| 12/20/2000 | CN1059673C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 12/20/2000 | CN1059669C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas compound |
| 12/19/2000 | US6162961 Absorbent article |
| 12/19/2000 | US6162920 Taxane derivatives having a pyridyl substituted C13 side chain, their preparation and their use as anti-tumor agents |
| 12/19/2000 | US6162918 Tetramethylacridinedione derivatives are inhibitors of herpes simplex virus thymidine kinase in the treatment and prophylaxis of infections caused by herpes simplex virus. |
| 12/19/2000 | US6162833 Photostable aqueous solution comprising benzyl alcohol derivatives |
| 12/19/2000 | US6162831 Prevention of gout; cardiovascular disorders |
| 12/19/2000 | US6162830 Antihistamines, antiallergens, bone disorders |
| 12/19/2000 | US6162829 (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| 12/19/2000 | US6162828 Cysteine protease inhibitor |
| 12/19/2000 | US6162827 Treatment of negative and cognitive symptoms of schizophrenia with D-serine |